The UK NSC recommendation on Spinal Muscular Atrophy
Find general information about population health screening.
Why is screening not recommended by UK NSC?
A review found that:
More about SMA
Spinal muscular atrophy (SMA) is a genetic disease that causes muscle weakness and a progressive loss of movement. There are four types of SMA that vary in terms of the age those sufferers develop symptoms and also the severity of the symptoms they can have. There is no cure but therapy and support are available to help manage the condition.
SMA causes the motor neurones in a certain area of the spinal cord to deteriorate. This can result in progressive muscle wasting and loss of ability to move parts of the body. SMA is rare, with an estimated 5,500 to 6,000 people with SMA at any one time in the UK.
The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.
More optionsGo to top